Inventiva S.A. (IVA) stock
IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
$3.22−0.10 (-3.01%)
Close on Nov 17, 2026Market cap $622.22MP/E –Yield –
Inventiva price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Inventiva's price to sales ratio was 189.5× on Nov 11, 2026, against 55.4× a year earlier. Over the last 5 years it ranged from 5.0× to 212.3×, with a median of 39.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 189.5× | +129.5 |
| 2025 | Dec 31, 2025 | 59.9× | +53.7 |
| 2024 | Dec 31, 2024 | 6.2× | −7.7 |
| 2023 | Dec 29, 2023 | 13.9× | −26.7 |
| 2022 | Dec 30, 2022 | 40.6× | −27.8 |
| 2021 | Feb 26, 2021 | 68.5× | +28.6 |
| 2020 | Dec 31, 2020 | 39.8× | – |
See a number that looks wrong?